These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 35877697

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
    Brennan CA, Nakatsu G, Gallini Comeau CA, Drew DA, Glickman JN, Schoen RE, Chan AT, Garrett WS.
    mBio; 2021 Apr 06; 12(2):. PubMed ID: 33824205
    [Abstract] [Full Text] [Related]

  • 3. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
    Queen J, Domingue JC, White JR, Stevens C, Udayasuryan B, Nguyen TTD, Wu S, Ding H, Fan H, McMann M, Corona A, Larman TC, Verbridge SS, Housseau F, Slade DJ, Drewes JL, Sears CL.
    mBio; 2021 Feb 22; 13(1):e0299121. PubMed ID: 35130731
    [Abstract] [Full Text] [Related]

  • 4. Development of a multiplex PCR assay and quantification of microbial markers by ddPCR for identification of saliva and vaginal fluid.
    Dass M, Ghai M.
    Forensic Sci Int; 2024 Sep 22; 362():112147. PubMed ID: 39067179
    [Abstract] [Full Text] [Related]

  • 5. Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer.
    Wu QL, Fang XT, Wan XX, Ding QY, Zhang YJ, Ji L, Lou YL, Li X.
    World J Gastroenterol; 2024 Apr 14; 30(14):2018-2037. PubMed ID: 38681125
    [Abstract] [Full Text] [Related]

  • 6. Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis.
    Huang X, Hong X, Wang J, Sun T, Yu T, Yu Y, Fang J, Xiong H.
    EBioMedicine; 2020 Nov 14; 61():103037. PubMed ID: 33039709
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
    Nosho K, Sukawa Y, Adachi Y, Ito M, Mitsuhashi K, Kurihara H, Kanno S, Yamamoto I, Ishigami K, Igarashi H, Maruyama R, Imai K, Yamamoto H, Shinomura Y.
    World J Gastroenterol; 2016 Jan 14; 22(2):557-66. PubMed ID: 26811607
    [Abstract] [Full Text] [Related]

  • 12. The Role of Fecal Fusobacterium nucleatum and pks+ Escherichia coli as Early Diagnostic Markers of Colorectal Cancer.
    Liu K, Yang X, Zeng M, Yuan Y, Sun J, He P, Sun J, Xie Q, Chang X, Zhang S, Chen X, Cai L, Xie Y, Jiao X.
    Dis Markers; 2021 Jan 14; 2021():1171239. PubMed ID: 34853619
    [Abstract] [Full Text] [Related]

  • 13. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of Fusobacterium Nucleatum to Probiotics Populations, Based on Their Antagonistic Effect.
    Guo S, Li L, Xu B, Li M, Zeng Q, Xiao H, Xue Y, Wu Y, Wang Y, Liu W, Zhang G.
    Clin Chem; 2018 Sep 14; 64(9):1327-1337. PubMed ID: 29914865
    [Abstract] [Full Text] [Related]

  • 14. Fabrication of hyaluronic acid-inulin coated Enterococcus faecium for colon-targeted delivery to fight Fusobacterium nucleatum.
    Zhu P, Meng L, Shu Y, Xu Y, Liu W, Bi Y, Xu J, Meng L, Li Y.
    Carbohydr Polym; 2024 Apr 01; 329():121797. PubMed ID: 38286561
    [Abstract] [Full Text] [Related]

  • 15. Circulating Bacterial DNA in Colorectal Cancer Patients: The Potential Role of Fusobacterium nucleatum.
    Koliarakis I, Lagkouvardos I, Vogiatzoglou K, Tsamandouras I, Intze E, Messaritakis I, Souglakos J, Tsiaoussis J.
    Int J Mol Sci; 2024 Aug 20; 25(16):. PubMed ID: 39201711
    [Abstract] [Full Text] [Related]

  • 16. Variable characteristics of bacteriocin-producing Streptococcus salivarius strains isolated from Malaysian subjects.
    Barbour A, Philip K.
    PLoS One; 2014 Aug 20; 9(6):e100541. PubMed ID: 24941127
    [Abstract] [Full Text] [Related]

  • 17. Fecal Fusobacterium nucleatum harbored virulence gene fadA are associated with ulcerative colitis and clinical outcomes.
    Li DH, Li ZP, Yan Zhang, Zhou GZ, Ren RR, Zhao HJ, Zhang NN, Li JF, Peng LH, Yang YS.
    Microb Pathog; 2021 Aug 20; 157():104964. PubMed ID: 34022363
    [Abstract] [Full Text] [Related]

  • 18. Fusobacterium nucleatum promotes liver metastasis in colorectal cancer by regulating the hepatic immune niche and altering gut microbiota.
    Yin H, Miao Z, Wang L, Su B, Liu C, Jin Y, Wu B, Han H, Yuan X.
    Aging (Albany NY); 2022 Feb 25; 14(4):1941-1958. PubMed ID: 35212644
    [Abstract] [Full Text] [Related]

  • 19. Detection of Fusobacterium nucleatum in stool and colonic tissues from Norwegian colorectal cancer patients.
    Tunsjø HS, Gundersen G, Rangnes F, Noone JC, Endres A, Bemanian V.
    Eur J Clin Microbiol Infect Dis; 2019 Jul 25; 38(7):1367-1376. PubMed ID: 31025134
    [Abstract] [Full Text] [Related]

  • 20. Fusobacterium nucleatum in the Colorectum and Its Association with Cancer Risk and Survival: A Systematic Review and Meta-analysis.
    Gethings-Behncke C, Coleman HG, Jordao HWT, Longley DB, Crawford N, Murray LJ, Kunzmann AT.
    Cancer Epidemiol Biomarkers Prev; 2020 Mar 25; 29(3):539-548. PubMed ID: 31915144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.